Genetic and expression analysis of the KCNRG gene in hepatocellular carcinomas

Experimental and Molecular Medicine

Volumn 38, Issue 3, 2006, Pages 247-255

  Yong, Gu Cho ^a   Chang, Jae Kim ^a   Jae, Hwi Song ^a   Duck, Joo Rhie ^a   Yong, Kyu Park ^a   Su, Young Kim ^a   Suk, Woo Nam ^a   Nam, Jin Yoo ^a   Jung, Young Lee ^a   Won, Sang Park ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Carcinoma, hepatocellular; KCNRG protein, human; Loss of heterozygosity; Mutation, missense; Potassium channels

Indexed keywords

ARGININE; POTASSIUM CHANNEL; PROTEIN KCNRG; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CODON; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER METASTASIS; MISSENSE MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HEPATITIS B VIRUS;

EID: 33745828097     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2006.30     Document Type: Article

References (28)

1. Abdul M, Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol Rep 2001;9:961-4
2. Allen DH, Lepple-Wienhues A, Cahalan MD. Ion channel phenotype of melanoma cell lines. J Membrane Biol 1997;155: 27-34
3. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1977;12:S294-S308
4. Crawley JJ, Furge KA. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol 2002;3:research0075
5. Hino O, Shows TB, Rogler CE. Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17:18 translocation. Proc Natl Acad Sci 1996;83:8338-42
6. Ivanov DV, Tyazhelova TV, Lemonnier L, Kononenko N, Pestove AA, Nihitin EA, Prevarskaya N, Skryma R, Panchin YV, Yankovsky NK, Baranova AV. A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3. FEBS Letters 2003;539:156-60
7. + channel currents in rat ventral prostate epithelial cells. Prostate 2001;51:201-10
8. Kumar V, Cotran RS, Robbins SL. Neoplasia. In Robbins Basic Pathology. 2003, 165-210, W. B. Saunders, Philadelphia
9. Kusano N, Okita K, Shirahashi H, Harada T, Shiraishi K, Oga A, Kawauchi S, Furuya T, Sasaki K. Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma. Cancer 2002;94:746-51
10. Mu D, Chen L, Zhang X, Lee LH, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KC, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, Jan LY, McCombie R, Wigler MH, Powers S. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 2003;3:297-302
11. Nakamura T, Tokino T, Nagaya T, Matsubara K. Microdeletion associated with the integration process of hepatitis B virus DNA. Nucleic Acids Res 1998;16:4865-73
12. Niketeghad F, Decker HJ, Caselmann WH, Lund P, Geissler F, Dienes HP, Schirmacher P. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 2001;85:697-704
13. Ogata N, Tokino T, Kamimura T, Asakura H. A comparison of the molecular structure of integrated hepatitis B virus genomes in hepatocellular carcinoma cells and hepatocytes derived from the same patient. Hepatology 1990;11:1017-23
14. Okabe H, Ikai I, Matsuo K, Satoh S, Momoi H, Kamikawa T, Katsura N, Nishitai R, Takeyama O, Fukumoto M, Yamaoka Y. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Hepatology 2000;31:1073-9
15. Park WS, Cho YG, Kim CJ, Song JW, Lee YS, Kim SY, Nam SW, Lee SH, Yoo NJ, Lee JY. Hypermethylation of the RUNX3 gene in hepatocellular carcinoma. Exp Mol Med 2005;37: 276-81
16. Rhie DJ, Kim MJ, Choi WS, Lee KH, Sung JH, Min DS, Yoon SH, Hahn SJ, Kim MS, Jo YH. Effect of somatostatin on cholecystokinin-induced amylase release in rat pancreatic acini. Pancreas 2001;23:102-8
17. Robbins WS. Molecular events in the pathogenesis of hepadnavirus associated hepatocellular carcinoma. Ann Rev Med 1994;45:297-323
18. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multi-step hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991;22:172-8
19. Shin HR, Jung KW, Won YJ, Park JG. KCCR-affiliated Hospitals. 2002 Annual report of the Korea central cancer registry: Based on registered data from 139 hospitals. Cancer Research and Treatment 2004;36:103-14
20. Skryma R, Van Coppenolle F, Dufy-Barbe L, Dufy B, Prevarskaya N. Characterization of Ca(2+)-inhibited potassium channels in the LNCaP human prostate cancer cell line. Receptors Channels 1999;6:241-53
21. Strobl JS, Wonderlin WF, Flynn DC. Mitogenic signal transduction in human breast cancer cells. Gen Pharmacol 1995;26:1643-9
22. Vaish M, Mishra A, Kaushal M, Mishra SK, Mittal B. Microsatellite instability and its correlation with clinicopathological features in a series of thyroid tumors prevalent in iodine deficient areas. Exp Mol Med 2004;36:122-9
23. Wonderline WF, Woodfork KA, Stroble JS. Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol 1995; 165:177-85
24. Wonderlin WF, Strobl JS. Potassium channels, proliferation and G1 progression. J Membrane Biol 1996;154:91-107
25. Wong CM, Lee JM, Lau TC, Fan ST, Ng IO. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma. Clin Cancer Res 2002;8:2266-72
26. Woodfork KA, Wonderlin WF, Peterson VA, Strobl JS. Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol 1995;162:163-71
27. 2+ influx in carcinoma cells of colon cancer. Life Sci 1999;65:55-62
28. Zondervan PE, Wink J, Alers JC, Ijzermans JN, Schalm SW, de Man RA, van Dekken H. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. J Pathol 2000;192:207-15